Consumer Defensive
Live Price
Offline$58.40
+1.11% today
1Y Change
-16.83%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Unilever PLC (UL) is a Consumer Defensive stock with a market cap of $111.43B and listed on NYSE. The stock last traded around $58.40 and down 16.8% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -16.9%, EPS growth of +16.5%, a dividend yield of 3.9%. What stands out right now is revenue -16.9%, EPS +16.5%, free cash flow -19.6% with operating margin 28.0% and ROIC 15.1%. The dividend matters to the case here, with a current yield around 3.9%. Valuation is more restrained than many high-expectation growth names at P/E 25.7 and price/sales 3.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines UL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
UL
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
UL Max Drawdown
-26.20%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for UL and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$52.4B
-12.7% YoY
FY Net Income
$6.0B
-20.8% YoY
Free Cash Flow
$6.9B
+17.8% YoY
Revenue Growth
-16.9%
EPS Growth
+16.5%
Gross Margin
67.0%
Net Margin
12.2%
Income statement
EUR
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 50.5B | 60.8B | 59.6B | 60.1B | 52.4B |
| Gross Profit | 23.7B | 60.8B | 25.2B | 24.2B | 22.2B |
| Operating Income | 10.1B | 9.4B | 9.8B | 10.8B | 8.7B |
| EBITDA | 11.5B | 13.0B | 11.1B | 10.6B | 11.4B |
| Net Income | 9.5B | 5.7B | 6.5B | 7.6B | 6.0B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
EUR
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3.9B | 6.1B | 4.2B | 4.3B | 3.4B |
| Total Assets | 70.4B | 79.8B | 75.3B | 77.8B | 75.1B |
| Total Liabilities | 52.9B | 57.2B | 54.5B | 56.1B | 55.3B |
| Shareholder Equity | 15.5B | 20.0B | 18.1B | 19.0B | 17.1B |
| Total Debt | 29.6B | 30.7B | 28.6B | 28.4B | 29.7B |
| Net Debt | 25.7B | 24.5B | 24.4B | 24.1B | 26.3B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
8.0B
+9.5% YoY
Capital Expenditures
1.1B
+23.9% YoY
Free Cash Flow
6.9B
+17.8% YoY
Key ratios
Gross Margin
67.0%
Operating Margin
28.0%
Net Margin
12.2%
ROE
26.0%
Debt / Equity
1.91x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.